H. B. Fuller Company (FUL) Earnings Call Analysis
NYSE · Basic Materials · Specialty Chemicals
Earnings Reports
-
HB Fuller (FUL) Q2 2026: AMS Acquisition to Quadruple Medical Revenue, Targets 100 bps Margin Gain
June 25, 2026
-
HB Fuller (FUL) Q1 2026: 10% Global Price Hike Offsets 7% Volume Slide Amid Supply Shock
March 26, 2026
-
HB Fuller (FUL) Q4 2025: EBITDA Margin Jumps 290bps as Portfolio Shift and Cost Actions Take Hold
January 15, 2026
-
HB Fuller (FUL) Q3 2025: EBITDA Margin Expands 110bps as Portfolio Shift Counters Volume Weakness
September 25, 2025
-
HB Fuller (FUL) Q2 2025: EBITDA Margin Expands 130bps as Portfolio Shift Offsets Volume Weakness
July 02, 2025